arrow
R

Robert B. Den

Thomas Jefferson University Hospital
H指数:55
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

局部高危前列腺癌的转录组学分析改善了预后判断,并确定了在NRG肿瘤学/RTOG 0521 III期试验中,将多西他赛添加到根治性放疗联合雄激素抑制治疗中获益。

2025-07-170
OAAI
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes

一种基于管腔和基底表型的新型前列腺癌亚型分类器

CANCER
IF5.1
2023-04-148
OAAI
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126

接受前列腺放疗的男性的身体成分和死亡率: NRG/RTOG 9406和NRG/RTOG 0126的汇总分析

CANCER
IF5.1
2022-12-295
PRE
Novel Transcriptomic Interactions Between Immune Content and Genomic Classifier Predict Lethal Outcomes in High-grade Prostate Cancer
2022-04-019
OAAI
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial
2022-02-0121
OAAI
Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience
2021-11-011
PRE
Transcriptional profiling of primary prostate tumor in metastatic hormonesensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

转移性激素敏感性前列腺癌中原发性前列腺肿瘤的转录谱及其与临床结果的关联: E3805 CHAARTED试验的相关分析

2021-09-0139
OAAI
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
2021-06-0357
OAAI
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
2021-04-2050
OA
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
2021-03-01113
PREAI